| Pfizer AG - Prevenar 13, Injektionssuspension in einer Fertigspritze |
| 60129 | | 01 | | Prevenar 13 | | Injektionssuspension in einer Fertigspritze | | J07AL02 | | Pneumokokken, gereinigtes Polysaccharid-Antigen, konjugiert | | 12.08.2010 | | |
|
| Composition |
| polysaccharida streptococci pneumoniae typus 1 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 4 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 5 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 6A conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 6B conjugata cum proteino corynebacteriae diphtheriae CRM 197 4.4 µg et polysaccharida streptococci pneumoniae typus 7F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 9V conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 14 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 18C conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 19A conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 19F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 23F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg corresp. polysaccharida 30.8 µg et proteinum corynebacteriae diphtheriae CRM 197 ca. 32 µg, adjuvans: aluminium ut aluminii phosphas, natrii chloridum corresp. natrium 1.67 mg, acidum succinicum, polysorbatum 80, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml. |
| Packungsbestandteile |
| Injektionssuspension in einer Fertigspritze | | | | | | | | Principe actif | Concentr. |
|---|
| Polysaccharida Streptococci Pneumoniae Typus 18c Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 19a Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 19f Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 23f Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml correspond Polysaccharida 30.8µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 6A Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 6B Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 4.4µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 7F Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 9V Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml |
| | BAG: Principe actif |
|---|
| Vaccinum Pneumococcale Polysaccharidicum crm Conjugatum 13-Valens |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acide Succinique | | | | Alumine | | adjuvans | | Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml | | | Sodium Chlorure | | | | Polysaccharida Streptococci Pneumoniae Typus | 14 | | | Polysorbatum 80 | | | | Proteinum Corynebacteriae Diphtheriae crm 197 | 32µg / 0.5ml | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | seringue prête à 0.5 ml | 58.03 | 83.10 | B | LS | Oui | | 002 | 10 1 seringue prête à 0.5 ml | DDP | DDP | B | | Oui |
|
